Shareholders Equity: The sum of preferred and common equity items.
Basilea Pharmaceutica AG (BPMUF) had Shareholders Equity of $125.05M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$263.61M |
|
$4.23M |
|
$38.04M |
|
$301.65M |
|
$41.69M |
|
$99.38M |
|
$134.92M |
|
$176.61M |
|
$125.05M |
|
$124.64M |
|
|
Shareholders Equity |
$125.05M |
12.28M |
|
| Cash Flow Statement Financials | |
$27.95M |
|
$-0.50M |
|
$-17.54M |
|
$150.99M |
|
$160.88M |
|
$9.89M |
|
$3.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|